Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MDxHealth SA - Ordinary Shares
(NQ:
MDXH
)
0.5859
+0.0659 (+12.67%)
Streaming Delayed Price
Updated: 3:09 PM EDT, Sep 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about MDxHealth SA - Ordinary Shares
< Previous
1
2
Next >
Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build
August 14, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as Revenue Growth Guidance Tops 500% – Plus More In Focus
August 14, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
Kartoon Studios (NYSE: TOON) Enters Next Growth Phase; Reports Q2 Revenue of $5.82M, EPS of $0.38 and $40.5M Cash Position – Plus More in Focus
August 14, 2026
Via
AB Newswire
Topics
Intellectual Property
Mdxhealth Reports Second Quarter 2026 Financial Results
August 13, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
July 30, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
July 24, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 02, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
June 29, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Reports Q1-2026 Results
May 13, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
April 30, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
March 16, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
February 12, 2026
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
January 12, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
January 06, 2026
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
November 12, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
November 03, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
September 15, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
August 05, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
July 03, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Q1-2025 Results
May 14, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
April 30, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
February 26, 2025
From
mdxhealth
Via
GlobeNewswire
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
February 12, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
January 13, 2025
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Participate in Piper Sandler Healthcare Conference
November 25, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
November 06, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
October 14, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25, 2024
From
mdxhealth
Via
GlobeNewswire
MDxHealth Announces Launch of Offering of Ordinary Shares
September 25, 2024
From
mdxhealth
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
